Journal of Tuberculosis and Lung Health ›› 2018, Vol. 7 ›› Issue (3): 161-166.doi: 10.3969/j.issn.2095-3755.2018.03.003
• Expert Note • Previous Articles Next Articles
Received:
2018-08-18
Online:
2018-09-30
Published:
2018-10-16
Contact:
Wei-wei GAO
E-mail:gwwjys@sina.com
Yan MA,Wei-wei GAO. Current situation and prospect of prevention and treatment among elderly tuberculosis[J]. Journal of Tuberculosis and Lung Health , 2018, 7(3): 161-166. doi: 10.3969/j.issn.2095-3755.2018.03.003
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.jtbld.cn/EN/10.3969/j.issn.2095-3755.2018.03.003
[1] | 中华人民共和国国务院人口普查办公室, 中华人民共和国国家统计局人口和就业统计司. 中国2010年人口普查资料. 北京: 中国统计出版社, 2012. |
[2] |
裴宁, 李波, 曹文利 , 等. 老年肺结核患者的耐药性分析. 中国防痨杂志, 2017,39(9):985-989.
doi: 10.3969/j.issn.1000-6621.2017.09.017 URL |
[3] |
Mori T, Leung CC . Tuberculosis in the global aging population. Infect Dis Clin North Am, 2010,24(3):751-768.
doi: 10.1016/j.idc.2010.04.011 URL pmid: 20674802 |
[4] |
Dye C, Maher D, Weil D , et al. Targets for global tuberculosis control. Int J Tuberc Lung Dis, 2006,10(4):460-462.
doi: 10.1183/09031936.06.00137405 URL pmid: 16602414 |
[5] |
Raviglione MC, Uplekar MW . WHO’s new stop TB strategy. Lancet, 2006,367(9514):952-955.
doi: 10.1016/S0140-6736(06)68392-X URL pmid: 16546550 |
[6] | World Health Organization. The global plan to stop TB, 2006—2015. Actions for life: towards a world free of tuberculosis. Geneva:World Health Organization, 2006. |
[7] | 中华人民共和国国务院办公厅. 国务院办公厅关于印发全国结核病防治规划(2011—2015年)的通知. 2011-11-17. |
[8] | Institute for Health Metrics and Evaluation. Global burden of disease: 2014. Seattle:Institute for Health Metrics and Evaluation, 2014. |
[9] |
Salvadó M, Garcia-Vidal C, Vázquez P , et al. Mortality of tuberculosis in very old people. J Am Geriatr Soc, 2010,58(1):18-22.
doi: 10.1111/j.1532-5415.2009.02619.x URL pmid: 20122037 |
[10] |
Tagaro M, Harries AD, Kool B , et al. Tuberculosis case burden and treatment outcomes in children, adults and older adults, Vanuatu, 2007—2011. Public Health Action, 2014,4(Suppl 1):S14-18.
doi: 10.5588/pha.13.0074 URL |
[11] |
Righi E, Della Siega P, Merelli M , et al. Comparison of clinical characteristics of tuberculosis between two age groups at an Italian Tertiary Hospital. Infection, 2015,43(3):361-366.
doi: 10.1007/s15010-015-0765-y URL |
[12] |
Ncube RT, Takarinda KC, Zishiri C , et al. Age-stratified tuberculosis treatment outcomes in Zimbabwe: are we paying attention to the most vulnerable? Public Health Action, 2017,7(3):212-217.
doi: 10.5588/pha.17.0024 URL |
[13] |
Patra S, Lukhmana S, Tayler Smith K , et al. Profile and treatment outcomes of elderly patients with tuberculosis in Delhi, India: implications for their management. Trans R Soc Trop Med Hyg, 2013,107(12):763-768.
doi: 10.1093/trstmh/trt094 URL |
[14] | Japan Ministry of Health, Labour and Welfare. Statistics of tuberculosis 2015 [Kekkaku no toukei]. Tokyo: Japan Anti-Tuberculosis Association, 2016. |
[15] |
Lefebvre N, Falzon D . Risk factors for death among tuberculosis cases: analysis of European surveillance data. Eur Respir J, 2008,31(6):1256-1260.
doi: 10.1183/09031936.00131107 URL pmid: 18515556 |
[16] |
Crofts JP, Pebody R, Grant A , et al. Estimating tuberculosis case mortality in England and Wales, 2001—2002. Int J Tuberc Lung Dis, 2008,12(3):308-313.
URL pmid: 18284837 |
[17] |
Hauer B, Brodhun B, Altmann D , et al. Tuberculosis in the elderly in Germany. Eur Respir J, 2011,38(2):467-470.
doi: 10.1183/09031936.00199910 URL pmid: 21804163 |
[18] |
Ananthakrishnan R, Kumar K, Ganesh M , et al. The profile and treatment outcomes of the older (aged 60 years and above) tuberculosis patients in Tamilnadu, South India. PLoS One, 2013,8(7):e67288.
doi: 10.1371/journal.pone.0067288 URL |
[19] |
Touré NO, Dia Kane Y, Diatta A , et al. Tuberculosis in elderly persons. Rev Mal Respir, 2010,27(9):1062-1068.
doi: 10.1016/j.rmr.2010.04.017 URL |
[20] |
Oshi DC, Oshi SN, Alobu I , et al. Profile and treatment outcomes of tuberculosis in the elderly in southeastern Nigeria, 2011—2012. PLoS One, 2014,9(11):e111910.
doi: 10.1371/journal.pone.0111910 URL |
[21] | 中华人民共和国卫生部. 1979全国结核病流行病学抽样调查资料汇编. 北京: 人民卫生出版社, 1981. |
[22] | 中华人民共和国卫生部. 1990全国结核病流行病学抽样调查资料汇编. 北京: 人民卫生出版社, 1992. |
[23] | 中华人民共和国卫生部. 2000年全国结核病流行病学抽样调查资料汇编.北京: 人民卫生出版社, 2003. |
[24] | 全国第五次结核病流行病学抽样调查技术指导组, 全国第五次结核病流行病学抽样调查办公室. 2010年全国第五次结核病流行病学抽样调查报告. 中国防痨杂志, 2012,34(8):485-508. |
[25] | Leung EC, Leung CC, Chang KC , et al. Delayed diagnosis of tuberculosis: risk factors and effect on mortality among older adults in Hong Kong. Hong Kong Med J, 2018,24(4):361-368. |
[26] |
周琳, 陈松华, 张钰 , 等. 2005—2014 年浙江省老年肺结核病流行病学特征分析. 疾病监测, 2016,31(8):647-650.
doi: 10.3784/j.issn.1003-9961.2016.08.008 URL |
[27] |
张玉, 叶建君, 杨成凤 , 等. 2006—2015年湖北省老年肺结核疫情特征及变化趋势分析. 中国防痨杂志, 2017,39(2):213-216.
doi: 10.3969/j.issn.1000-6621.2017.02.021 URL |
[28] | 陈勇, 沈鑫, 潘启超 , 等. 上海市1999—2006年新登记老年肺结核患者死亡情况及影响因素分析. 中国防痨杂志, 2012,34(12):784-789. |
[29] |
Negin J, Abimbola S, Marais BJ . Tuberculosis among older adults—time to take notice. Int J Infect Dis, 2015,32:135-137.
doi: 10.1016/j.ijid.2014.11.018 URL pmid: 25809769 |
[30] |
Coffman J, Chanda-Kapata P, Marais BJ , et al. Tuberculosis among older adults in Zambia: burden and characteristics among a neglected group. BMC Public Health, 2017,17(1):804.
doi: 10.1186/s12889-017-4836-0 URL pmid: 5639764 |
[31] | Walubo A, Chan K, Woo J , et al. The disposition of antituberculous drugs in plasma of elderly patients. II. Isoniazid, rifampicin, and pyrazinamide. Methods Find Exp Clin Pharmacol, 1991,13(8):551-556. |
[32] | Walubo A, Chan K, Woo J , et al. The disposition of antituberculous drugs in plasma of elderly patients. I. Isoniazid and hydrazine metabolite. Methods Find Exp Clin Pharmacol, 1991,13(8):545-550. |
[33] |
Huang YS, Chern HD, Su WJ , et al. Polymorphism of the N-acetyltransferase 2 gene as a susceptibility risk factor for antituberculosis drug-induced hepatitis. Hepatology, 2002,35(4):883-889.
doi: 10.1053/jhep.2002.32102 URL |
[34] |
Teleman MD, Chee CB, Earnest A , et al. Hepatotoxicity of tuberculosis chemotherapy under general programme conditions in Singapore. Int J Tuberc Lung Dis, 2002,6(8):699-705.
doi: 10.4028/www.scientific.net/MSF.264-268.1073 URL pmid: 12150482 |
[35] | Fernández-Villar A, Sopeña B, Fernández-Villar J , et al. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity. Int J Tuberc Lung Dis, 2004,8(12):1499-1505. |
[36] | 刘险锋, 唐俊 . 中国高龄老人的社会保障问题初探. 中国行政管理, 2011, ( 6):20-23. |
[37] | 张静, 李文胜, 高微微 . 抗结核药物治疗致患者肝损伤死亡二例并文献复习. 结核病与肺部健康杂志, 2017,6(1):73-76. |
[38] | Chino H, Hagiwara E, Sekine A , et al. Compliance rate of standard treatment regimen and optimal dose of anti-tuberculosis drugs in late elderly patients with pulmonary tuberculosis. Kekkaku, 2016,91(5):495-502. |
[39] | 戈启萍, 高微微, 孔忠顺 , 等. 三种不同治疗方案治疗103例老年初治涂阳肺结核的疗效及安全性观察. 中国防痨杂志, 2006,28(3):152-155. |
[40] | 戈启萍, 孔忠顺, 卜建玲 , 等. 95例住院高龄肺结核临床分析. 中国防痨杂志, 2000,22(4):188-191. |
[41] | 高微微, 段连山, 黄学锐 , 等. 合并糖尿病肺结核与无糖尿病结核病人的三种抗结核药物药代动力学观察. 中国防痨杂志, 2003,25(2):71-74. |
[42] | 李艳静, 高微微, 常占平 , 等. 肺结核合并糖尿病对抗结核药物血药浓度的影响. 中国防痨杂志, 2012,34(1):23-25. |
[43] | 高微微, 李琦, 高孟秋 , 等. 特殊人群结核病治疗. 北京: 科学出版社, 2011. |
[44] |
Kuwabara K . Anti-tuberculosis chemotherapy and management of adverse reactions. Nihon Rinsho, 2011,69(8):1389-1393.
URL pmid: 21838035 |
[45] |
Shang P, Xia Y, Liu F , et al. Incidence, clinical features and impact on anti-tuberculosis treatment of anti-tuberculosis drug induced liver injury (ATLI) in China. PLoS One, 2011,6(7):e21836.
doi: 10.1371/journal.pone.0021836 URL |
[46] | 中国疾病预防控制中心. 中国结核病监测报告(2015年). 北京:中国疾病预防控制中心, 2015. |
[47] |
廖培军, 邱勇, 郭明成 , 等. 四川省武胜县农村地区主动发现结核病患者调查分析. 中国防痨杂志, 2016,38(7):576-581.
doi: 10.3969/j.issn.1000-6621.2016.07.012 URL |
[48] | 中华人民共和国国务院办公厅. 国务院办公厅关于印发“十三五”全国结核病防治规划的通知. 2017 -02-16. |
[49] | 张灿有, 王黎霞, 张慧 , 等. 不同发现策略应用于老年肺结核患者发现的成本效果研究. 中国防痨杂志, 2013,35(10):793-798. |
[50] |
Byng-Maddick R, Noursadeghi M . Does tuberculosis threaten our ageing populations? BMC Infect Dis, 2016,16:119.
doi: 10.1186/s12879-016-1451-0 URL pmid: 4787032 |
[1] | Chen Yu, Li Xiaorui, Wang Miaoran, Zhang Yuqi, Liu Chang, Wang Zhaohua, Shi Jie, Fan Lichao, Yin Zhihua, Xie Jianping. The research progress on the role of metal ions in tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 102-112. |
[2] | Xu Yannan, Fang Zihao, Zhao Wenli, Zheng Jiaxiong, Liu Suyang, Lin Jianxiong, Ji Liwei, Chang Qiaocheng. Characterisation of isoniazid-resistant Mycobacterium tuberculosis mutations in China [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 14-21. |
[3] | Wan Ying, Pang Xuewen, Zhang Fan. Evaluation on effect of health promotion for tuberculosis prevention and control in Tianjin City from 2010 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 22-29. |
[4] | Zhao Yongnian, Zhang Lijie, Wang Tongmin. Analysis of the epidemiological characteristics of reported pulmonary tuberculosis in Xinjiang Production and Construction Corps, 2014—2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 30-34. |
[5] | Zheng Jianli, Wu Yumei, Zhang Shili, Du Zixian, Li Turong, Chen Shisheng, Lin Wenge. Cost-effectiveness analysis of active tuberculosis screening among high-risk populations in Longyan City, Fujian Province [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 35-39. |
[6] | Yang Yan, Dong Wen, Chen Jianjun, Zhang Yu. Epidemiologic characteristics of pulmonary tuberculosis in Zhuxi County, Shiyan City (2014-2023) [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 40-45. |
[7] | Qi Wei, Zhao Enyi. The epidemic characteristics and the trends of pulmonary tuberculosis in elderly and non-elderly in central urban area, Tianjin from 2006 to 2020 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 46-54. |
[8] | Yan Qinghu, Xue Feng, Yu Yong, Qin Yi, Yan Qingmei, Cui Jia. The value of ultrasound-guided microwave ablation in the treatment of localized tuberculous lesions [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 55-60. |
[9] | Chen Jing, Qin Yali, Wang Mingdong, Yang Rubin, Wang Qian, Peng Yanqing, Qiu Jiyao, Zhang Xiao, Zhou Xinai. The value of QuantiFERON-TB Gold Plus in the clinical diagnosis of active pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 61-67. |
[10] | Gu Jinhua, Zhang Panpan. Evaluation of the application value of three detection methods for Mycobacterium tuberculosis in a comprehensive hospital [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 68-72. |
[11] | Yan Wenhua, Chen Wenjun. The value of digital health education in the preventive management of caregivers of patients with bacterial positive pulmonary tuberculosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 73-78. |
[12] | Liao Ying, Pang Yan, Zhao Jing, He Gaoqin, You Maolin, Wang Lei. Analysis on the reporting and case finding delay characteristics of pulmonary tuberculosis patients in Liangping District, Chongqing from 2018 to 2023 [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 8-13. |
[13] | Zhang Ying, Guo Chunhui. Research progress in the treatment of tuberculous tracheobronchial stenosis [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 87-93. |
[14] | Yang Shuqi, Li Feng. Advances in PD1/PD-L1 inhibitors in tuberculosis research [J]. Journal of Tuberculosis and Lung Disease, 2025, 6(1): 94-101. |
[15] | Hu Xinyang, Gao Jingtao. Interpretation of WHO global tuberculosis report 2024 [J]. Journal of Tuberculosis and Lung Disease, 2024, 5(6): 500-504. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||